The emerging pathogen Candida auris is isolated mostly from hospitalized patients and often shows multidrug resistance. We report on the isolation of this yeast in Austria from an outpatient’s auditory canal. The isolate showed good susceptibility against antifungals except for echinocandins; the patient was treated successfully with topical administration of nystatin.
CITATION STYLE
Pekard-Amenitsch, S., Schriebl, A., Posawetz, W., Willinger, B., Kölli, B., & Buzina, W. (2018, August 1). Isolation of Candida auris from ear of otherwise healthy patient, Austria, 2018. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2408.180495
Mendeley helps you to discover research relevant for your work.